Brain+ has been selected as showcase in the HealthTech category, among other top cutting-edge start-ups from
Digital Hub Denmark is a public-private partnership between the Danish Government, the
Watch the Brain+ digital showcase video here https://vimeo.com/691303530/e3601eee6d
About Digital Hub Denmark
Mission: To make
https://digitalhubdenmark.dk/founded-in-denmark/
About BRAIN+ [BRAINP]
PROBLEM: Dementia is a terrible condition, crippling a person's independence and putting a heavy burden also on the family. With an aging population, dementia - and in particular Alzheimer's dementia - is a growing problem, threatening to overwhelm the health care systems of the world. So far, attempts to develop effective drug-based therapies have failed, and focus is shifting towards new non-drug therapies that cane pave the way to help relieve the heavy burden of dementia - for people living with the disease, their relatives and healthcare systems.
VISION. Making effective Alzheimer's and dementia treatments available to everyone, as digital medicine
MISSION: To restore independence and quality of life by treating and detecting cognitive decline in people living withAlzheimer's disease and dementia.
SOLUTION: Together with world-leading experts and institutions, we are digitizing the best-in-class, non-drug dementia therapies, making them available on regular digital devices - both in people's homes and at the clinics. A therapy here, simply means a person having to actively do something, interacting with a software program or another person, which is stimulating to the brain, or which results in changes in behavior that brings measurable health benefits. Our digital therapeutic solutions also benefit the patient care givers in their work and can help ease the pressure on the health care systems.
DIGITAL & DRUGS: Software-as-medical treatments can be used on their own or be combined with traditional drug treatments. We believe the future will combine the best of both the digital and the pharmacological world for mutually enhancing benefits, including synergies in compliance, patient engagement and mechanisms of action for better health outcomes.
PERSONLIZED, DATA-DRIVEN MEDICINE: We believe a key benefit of digital medicine is also to proactively collect and use data to create tailored and more effective personalized therapy experiences, and to help improve clinical and scientific practice, while always adhering to strict ethical standards of personal data protection.
OUR DNA: We are a digital biotech company. Our technologies and products are being built on a deep understanding of the challenges and needs associated with dementia, rigorously tested, scientifically and clinically validated, and regulated as software-as-medical-devices(/treatments). These treatments will be prescribed by health care professionals and paid for by health insurance or state health care.
POTENTIAL: In 2030, the global costs of dementia are expected to be
TEAM & TECH: We have built our knowledge base, know-how and network of global expert collaborators over 10 years, and our technology portfolio is the results of R&D investments of over €10 million, which puts us in a unique position to become a global market leader in digital therapeutic solutions for dementia and Alzheimer's. We have a senior management team with a combined 100 years of track-record, with backgrounds from companies such as
Read more & watch latest video updates: https://www.brain-plus.com/investor/
https://news.cision.com/brain--a-s/r/brain--selected-as--digital-showcase-for-denmark--by-digital-hub-denmark,c3532038
https://mb.cision.com/Public/20893/3532038/a7ecf27a35432cee.pdf
https://news.cision.com/brain--a-s/i/1-b-en-rgb,c3029125
(c) 2022 Cision. All rights reserved., source